Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis

Murat Kantarcıoğlu, Hakan Demirci, Ferit Avcu, Yıldırım Karslıoğlu, Bilal Babayiğit, Bülent Karaman, Kadir Öztürk, Hasan Gürel, Meral Akdoğan Kayhan, Sabite Kaçar, Ayhan Kubar, G. Öksüzoğlu, Ali Uğur Ural, Sait BağcıThe Turkish Journal of Gastroenterology 2015 · DOI

Abstract

Autologous mesenchymal stem cell transplantation via peripheral vein is safe and feasible. Consecutive liver biopsy examinations suggested that mesenchymal stem cells could not reach the liver in a sufficient amount. Improvement in patients and clearance of HCV RNA may have occurred through immunomodulatory mediators secreted by transplanted mesenchymal stem cells, namely the "endocrine" effect.
BibTeX
@article{kantarcoglu2015efficacy,
  author = {Murat Kantarcıoğlu and Hakan Demirci and Ferit Avcu and Yıldırım Karslıoğlu and Bilal Babayiğit and Bülent Karaman and Kadir Öztürk and Hasan Gürel and Meral Akdoğan Kayhan and Sabite Kaçar and Ayhan Kubar and G. Öksüzoğlu and Ali Uğur Ural and Sait Bağcı},
  title = {{Efficacy of autologous mesenchymal stem cell transplantation in patients with liver cirrhosis}},
  journal = {The Turkish Journal of Gastroenterology},
  year = {2015},
  doi = {10.5152/tjg.2015.0074},
}

Loading related content...

Figure